RRA
PFE icon

Round Rock Advisors’s Pfizer PFE Stock Holding History

Round Rock Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$440K Sell
18,270
-11,946
-40% -$312K 0.06% 230
2026
Q1 		$848K Sell
30,216
-1,544
-5% -$41.1K 0.13% 125
2025
Q4 		$791K Buy
31,760
+2,292
+8% +$57.8K 0.12% 134
2025
Q3 		$751K Buy
29,468
+12,980
+79% +$320K 0.12% 117
2025
Q2 		$400K Buy
16,488
+742
+5% +$17.3K 0.07% 151
2025
Q1 		$399K Buy
15,746
+1,402
+10% +$36.7K 0.07% 147
2024
Q4 		$381K Sell
14,344
-6,268
-30% -$170K 0.08% 146
2024
Q3 		$597K Sell
20,612
-221
-1% -$6.45K 0.14% 99
2024
Q2 		$583K Sell
20,833
-4,178
-17% -$115K 0.14% 99
2024
Q1 		$694K Buy
25,011
+148
+0.6% +$4.11K 0.17% 98
2023
Q4 		$716K Sell
24,863
-11,398
-31% -$345K 0.18% 91
2023
Q3 		$1.2M Hold
36,261
– – 0.46% 39
2023
Q2 		$1.33M Buy
36,261
+944
+3% +$36.7K 0.48% 37
2023
Q1 		$1.44M Sell
35,317
-4,185
-11% -$181K 0.55% 31
2022
Q4 		$2.02M Sell
39,502
-107
-0.3% -$5.13K 0.83% 17
2022
Q3 		$1.73M Buy
39,609
+7,400
+23% +$360K 0.78% 20
2022
Q2 		$1.69M Buy
32,209
+5,552
+21% +$283K 0.76% 21
2022
Q1 		$1.38M Buy
26,657
+16,498
+162% +$856K 0.56% 33
2021
Q4 		$600K Buy
10,159
+3,063
+43% +$152K 0.27% 66
2021
Q3 		$305K Buy
7,096
+626
+10% +$27.7K 0.23% 45
2021
Q2 		$253K Buy
6,470
+881
+16% +$34.3K 0.18% 56
2021
Q1 		$202K Hold
5,589
– – 0.16% 66
2020
Q4 		$205K Buy
+5,589
New +$205K 0.19% 53

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Round Rock Advisors's PFE Position: Q2 2026 in Review

Round Rock Advisors reduced its Pfizer (PFE) stake by 40% in Q2 2026, selling an estimated $312K and leaving 18,270 shares worth $440K. The position accounts for 0.06% of the portfolio, ranked #230.

Round Rock Advisors first reported a position in PFE in Q4 2020 and has held it in 23 quarters since. The position peaked at $2.02M in Q4 2022. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Round Rock Advisors held 18,270 shares of Pfizer worth $440K as of Q2 2026.
  • Round Rock Advisors sold 11,946 Pfizer shares in Q2 2026, an estimated $312K.
  • Pfizer made up 0.06% of Round Rock Advisors's portfolio in Q2 2026, its #230 holding.
  • Round Rock Advisors first reported a position in Pfizer in Q4 2020 and has held it in 23 quarters since.
  • Round Rock Advisors's Pfizer position peaked at $2.02M in Q4 2022.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Round Rock Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.